(Q38814371)

6 September 2017

Cardiac issues in adults with the mucopolysaccharidoses: current knowledge and emerging needs (English)

1 reference

6 September 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27102649%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

author name string

Raymond Wang

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27102649%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

language of work or name

English

0 references

publication date

21 April 2016

1 reference

6 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27102649%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

volume

102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27102649%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

issue

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27102649%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

page(s)

1257-1262

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27102649%20AND%20SRC:MED&resulttype=core&format=json

The natural history of MPS I: global perspectives from the MPS I Registry

4 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-309258

Sanfilippo syndrome: Overall review

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-309258

The Morquio A Clinical Assessment Program: baseline results illustrating progressive, multisystemic clinical impairments in Morquio A subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-309258

Mutations and polymorphisms in GUSB gene in mucopolysaccharidosis VII (Sly Syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-309258

Lysosomal storage disorder screening implementation: findings from the first six months of full population pilot testing in Missouri

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-309258

Myocardial extracellular matrix: an ever-changing and diverse entity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-309258

Molecular characteristics of patients with glycosaminoglycan storage disorders in Russia

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-309258

Diagnosis and management of ophthalmological features in patients with mucopolysaccharidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-309258

Cardiac abnormalities in adults with the attenuated form of mucopolysaccharidosis type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-309258

Report of a Large Brazilian Family With a Very Attenuated Form of Hunter Syndrome (MPS II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-309258

Clinical characteristics of adults with slowly progressing mucopolysaccharidosis VI: a case series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-309258

Is Sanfilippo type B in your mind when you see adults with mental retardation and behavioral problems?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-309258

Mucopolysaccharidoses and other lysosomal storage diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-309258

Hunter syndrome with its typical heart: a close mimic to rheumatic heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-309258

Transplant outcomes in mucopolysaccharidoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-309258

Natural history and galsulfase treatment in mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy syndrome)--10-year follow-up of patients who previously participated in an MPS VI Survey Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-309258

The heart in the Hurler syndrome: gross, histologic and ultrastructural observations in five necropsy cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-309258

Japan Elaprase Treatment (JET) study: idursulfase enzyme replacement therapy in adult patients with attenuated Hunter syndrome (Mucopolysaccharidosis II, MPS II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-309258

Childhood onset of Scheie syndrome, the attenuated form of mucopolysaccharidosis I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-309258

Management of aortic stenosis in mucopolysaccharidosis type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-309258

The first cardiac transplant experience in a patient with mucopolysaccharidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-309258

Management of mucopolysaccharidosis type IH (Hurler's syndrome) presenting in infancy with severe dilated cardiomyopathy: a single institution's experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-309258

Unexpected coronary artery findings in mucopolysaccharidosis. Report of four cases and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-309258

Retrospective analysis of the clinical manifestations and survival of Korean patients with mucopolysaccharidosis type II: emphasis on the cardiovascular complication and mortality cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-309258

Intravascular ultrasound assessment of coronary artery involvement in Fabry disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-309258

Cerebral infarction in Hunter syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-309258

International guidelines for the management and treatment of Morquio A syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-309258

Therapy for the mucopolysaccharidoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-309258

Anaesthesia and airway management in mucopolysaccharidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-309258

2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-309258

2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of A

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-309258

Patterns in the prevalence of congenital heart defects, metropolitan Atlanta, 1978 to 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-309258

10.1136/HEARTJNL-2015-309258

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27102649%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

1 reference